http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1709202-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44df766f7fca9d1c4f11e8e597b09ef1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate | 2005-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fbe70e51224cda14dc30247edaa7484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62023d6985abfd4f98a690d795506f09 |
| publicationDate | 2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1709202-A1 |
| titleOfInvention | A141s and g399s mutation in the omi/htra2 protein in parkinson's disease |
| abstract | The invention relates to a method for the diagnosis of Parkinson's disease in a human being, to nucleic acid molecules used in said method, to the uses thereof in order to detect a nucleic acid molecule coding for human Omi/HtrA2 protein and/or for amplifying the human Omi/HtrA2 gene; to the use of a nucleic acid molecule which codes Omi/HtrA2 protein or sections thereof which is genetically modified in relation to the wild type, and/or one such protein and/or sections thereof for the diagnosis of Parkinson's disease and/or predisposition thereof; a nucleic acid molecule which codes for a human Omi/HtrA2 protein which is genetically modified in relation to the wild type on the 141 and/or 399 amino acid position, in addition to corresponding sections thereof; a host, preferably a transgenic non-human mammal, wherein one such nucleic acid molecule is introduced; a (poly)peptide which is coded by one such nucleic acid molecule; a method which is used to detect substances binding Omi/HtrA2 protein which is genetically modified in relation to the wild type; a substance discovered by means of said method in addition to, preferably, a pharmaceutical composition comprising one such substance. The invention further relates to a kit comprising at least one of the above-mentioned nucleic-acid molecules. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140137145-A |
| priorityDate | 2004-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.